| Literature DB >> 28201999 |
Ivonne Lozano-Pope1, Arnika Sharma2, Michael Matthias1, Kelly S Doran2, Marygorret Obonyo3.
Abstract
BACKGROUND: Gastric cancer is one of the most common and lethal type of cancer worldwide. Infection with Helicobacter pylori (H. pylori) is recognized as the major cause of gastric cancer. However, it remains unclear the mechanism by which Helicobacter infection leads to gastric cancer. Furthermore, the underlying molecular events involved during the progression of Helicobacter infection to gastric malignancy are not well understood. In previous studies, we demonstrated that that H. felis-infected Myd88 -/- mice exhibited dramatic pathology and an accelerated progression to gastric dysplasia; however, the MyD88 downstream gene targets responsible for this pathology have not been described. This study was designed to identify MyD88-dependent genes involved in the progression towards gastric cancer during the course of Helicobacter infection.Entities:
Keywords: Gastric cancer; Gene regulation; Helicobacter; Microarray; MyD88
Mesh:
Substances:
Year: 2017 PMID: 28201999 PMCID: PMC5310019 DOI: 10.1186/s12885-017-3114-y
Source DB: PubMed Journal: BMC Cancer ISSN: 1471-2407 Impact factor: 4.430
Fig. 1Multi Dimensional Scale Plot of all H. felis infected and control samples from WT and Myd88 −/− mice. Samples were separated using 8 RNA SEQ libraries based on sample relations of 23,015 genes with a standard deviation/ mean >0.1 Groups separated into infected Myd88 , infected WT and uninfected samples
Summary of microarray-based analysis of DEGs
| Strain | UP | DOWN | TOTAL |
|---|---|---|---|
| WT 25 weeks | 7 | 3 | 10 |
| WT 47 weeks | 189 | 87 | 276 |
|
| 1031 | 958 | 1989 |
|
| 1140 | 1022 | 2162 |
Number of differentially regulated genes at 25 weeks and 47 weeks in Myd88 and WT mice infected with H. felis compared to their matched uninfected controls. In total 23,015 genes were analyzed in both mouse backgrounds. Totals depict number of DEGs, both up and downregulated
Fig. 2Venn diagram of differentially expressed genes. The number of changed genes following infection with H. felis in WT and Myd88 mice at 25 and 47 weeks (p < 0.05) is shown. The relationship between these DEGS is also shown
Fig. 3Scatterplot of Differentially Expressed Genes in H. felis- infected Myd88 samples at (a) 25 and (b) 47 weeks. Scatterplot represents a summary of t-tests for individual genes, depicting the Log2 fold changes and their corresponding –log10 p-values of all differentially expressed genes from microarray analysis. Genes were separated into different time points. Negative values of Log2 fold changes indicate downregulated genes. Positive Log2 fold changes indicate upregulated genes. Genes with a fold change < 2.0 and a p value <0.05 are depicted as red dots and genes not found to be significantly altered are depicted as black dots. All infected animals were normalized to uninfected control mice at the same time point
Top 50 most differentially expressed annotated genes in H. felis-infected Myd88 mice at 25 weeks compared to uninfected controls
| Symbol | Gene Name | LogFC | Adj. P.Val |
|---|---|---|---|
| Chil4 | chitinase-like 4 | 5.77 | 4.05E-04 |
| Bpifb1 | BPI fold containing family B, member 1 | 4.90 | 1.97E-04 |
| Cd74 | CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated) | 4.28 | 4.93E-08 |
| H2-Ab1 | histocompatibility 2, class II antigen A, beta 1 | 4.09 | 2.35E-07 |
| Ido1 | indoleamine 2,3-dioxygenase 1 | 3.88 | 1.39E-04 |
| H2-DMa | histocompatibility 2, class II, locus DMa | 3.34 | 1.29E-05 |
| H2-DMb2 | histocompatibility 2, class II, locus Mb2 | 3.33 | 2.22E-06 |
| Igtp | interferon gamma induced GTPase | 3.29 | 1.54E-04 |
| H2-Eb1 | histocompatibility 2, class II antigen E beta | 3.28 | 2.51E-06 |
| Gbp2 | guanylate binding protein 2 | 3.27 | 3.49E-05 |
| Sftpd | surfactant associated protein D | 3.26 | 3.73E-07 |
| Psmb8 | proteasome (prosome, macropain) subunit, beta type 8 (large multifunctional peptidase 7) | 2.92 | 3.46E-06 |
| H2-K2 | histocompatibility 2, K region locus 2 | 2.78 | 2.64E-07 |
| H2-K1 | histocompatibility 2, K1, K region | 2.64 | 1.04E-06 |
| B2m | beta-2 microglobulin | 2.59 | 3.46E-06 |
| Pkp4 | plakophilin 4 | 2.54 | 2.04E-06 |
| H2-DMb1 | histocompatibility 2, class II, locus Mb1 | 2.52 | 3.46E-06 |
| Ubd | ubiquitin D | 2.51 | 2.90E-04 |
| H2-Aa | histocompatibility 2, class II antigen A, alpha | 2.47 | 2.15E-05 |
| Irgm2 | immunity-related GTPase family M member 2 | 2.42 | 9.04E-05 |
| H2-Q7 | histocompatibility 2, Q region locus 7 | 2.32 | 2.22E-06 |
| Cxcl9 | chemokine (C-X-C motif) ligand 9 | 2.30 | 6.23E-05 |
| Irf1 | interferon regulatory factor 1 | 2.23 | 7.54E-05 |
| Serpina3g | serine (or cysteine) peptidase inhibitor, clade A, member 3G | 2.22 | 5.85E-06 |
| H2-M2 | histocompatibility 2, M region locus 2 | 2.21 | 5.85E-06 |
| Casp1 | caspase 1 | 2.17 | 1.86E-04 |
| H2-D1 | histocompatibility 2, D region locus 1 | 2.17 | 1.07E-06 |
| Ear2 | eosinophil-associated, ribonuclease A family, member 2 | 2.16 | 6.91E-04 |
| H2-T23 | histocompatibility 2, T region locus 23 | 2.07 | 5.85E-06 |
| Psmb9 | proteasome (prosome, macropain) subunit, beta type 9 (large multifunctional peptidase 2) | 2.05 | 1.54E-04 |
| Psmb10 | proteasome (prosome, macropain) subunit, beta type 10 | 2.03 | 5.50E-05 |
| Sgk1 | serum/glucocorticoid regulated kinase 1 | −2.01 | 3.48E-04 |
| Apoa4 | apolipoprotein A-IV | −2.31 | 2.33E-05 |
| Ttr | transthyretin | −2.37 | 2.15E-05 |
| Fabp3 | fatty acid binding protein 3, muscle and heart | −2.37 | 1.61E-04 |
| Muc5ac | mucin 5, subtypes A and C, tracheobronchial/gastric | −2.41 | 7.14E-04 |
| Smim24 | small integral membrane protein 24 | −2.61 | 3.46E-06 |
| Lpl | lipoprotein lipase | −2.75 | 8.29E-05 |
| Pdia2 | protein disulfide isomerase associated 2 | −3.08 | 3.10E-05 |
| Pnliprp1 | pancreatic lipase related protein 1 | −3.18 | 5.76E-04 |
| Gm5771 | predicted gene 5771 | −3.36 | 3.53E-04 |
| Hamp2 | hepcidin antimicrobial peptide 2 | −3.43 | 1.59E-04 |
| Pnliprp2 | pancreatic lipase-related protein 2 | −3.44 | 7.47E-04 |
| Rnase1 | ribonuclease, RNase A family, 1 (pancreatic) | −3.78 | 5.55E-04 |
| Try5 | trypsin 5 | −4.17 | 7.45E-04 |
| Gm5409 | predicted pseudogene 5409 | −4.44 | 4.89E-05 |
| Try4 | trypsin 4 | −4.87 | 4.39E-05 |
| Try10 | trypsin 10 | −5.08 | 2.69E-06 |
| Amy2a5 | amylase 2a5 | −6.44 | 2.22E-06 |
| Chia1 | chitinase, acidic 1 | −6.68 | 8.93E-05 |
Genes with no known annotated name were excluded from the analysis. Genes were considered to be statistically significant when a threshold adjusted p value < 0.05 and Log FC > 2 were reached
Top 50 most differentially expressed annotated genes in H. felis-infected Myd88 mice at 47 weeks compared to uninfected controls
| Gene Symbol | Gene Name | LogFC | Adj. P.Val |
|---|---|---|---|
| Chil4 | chitinase-like 4 | 4.97 | 1.24E-03 |
| Cd74 | CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated) | 4.18 | 7.41E-08 |
| Bpifb1 | BPI fold containing family B, member 1 | 4.02 | 6.43E-04 |
| H2-Ab1 | histocompatibility 2, class II antigen A, beta 1 | 3.96 | 4.14E-07 |
| Ido1 | indoleamine 2,3-dioxygenase 1 | 3.78 | 1.44E-04 |
| Igtp | interferon gamma induced GTPase | 3.29 | 1.25E-04 |
| Sftpd | surfactant associated protein D | 3.24 | 4.86E-07 |
| H2-DMb2 | histocompatibility 2, class II, locus Mb2 | 3.20 | 4.43E-06 |
| Psmb8 | proteasome (prosome, macropain) subunit, beta type 8 (large multifunctional peptidase 7) | 3.20 | 1.71E-06 |
| Gbp2 | guanylate binding protein 2 | 3.15 | 4.53E-05 |
| H2-DMa | histocompatibility 2, class II, locus DMa | 3.13 | 2.17E-05 |
| H2-Eb1 | histocompatibility 2, class II antigen E beta | 3.05 | 6.39E-06 |
| Ubd | ubiquitin D | 2.85 | 8.22E-05 |
| B2m | beta-2 microglobulin | 2.81 | 4.14E-07 |
| H2-K2 | histocompatibility 2, K region locus 2 | 2.58 | 7.37E-07 |
| H2-Aa | histocompatibility 2, class II antigen A, alpha | 2.56 | 1.39E-05 |
| Irgm2 | immunity-related GTPase family M member 2 | 2.53 | 5.62E-05 |
| H2-DMb1 | histocompatibility 2, class II, locus Mb1 | 2.47 | 5.72E-06 |
| H2-K1 | histocompatibility 2, K1, K region | 2.40 | 3.89E-06 |
| Serpina3g | serine (or cysteine) peptidase inhibitor, clade A, member 3G | 2.30 | 4.90E-06 |
| Psmb9 | proteasome (prosome, macropain) subunit, beta type 9 (large multifunctional peptidase 2) | 2.30 | 4.92E-05 |
| Psmb10 | proteasome (prosome, macropain) subunit, beta type 10 | 2.29 | 1.49E-05 |
| Pigr | polymeric immunoglobulin receptor | 2.29 | 2.37E-05 |
| Oasl2 | 2′-5′ oligoadenylate synthetase-like 2 | 2.24 | 6.52E-04 |
| H2-Q7 | histocompatibility 2, Q region locus 7 | 2.22 | 4.90E-06 |
| Casp1 | caspase 1 | 2.20 | 1.33E-04 |
| Irf1 | interferon regulatory factor 1 | 2.17 | 8.33E-05 |
| C3 | complement component 3 | 2.15 | 4.52E-05 |
| Cxcl9 | chemokine (C-X-C motif) ligand 9 | 2.14 | 1.04E-04 |
| Pkp4 | plakophilin 4 | 2.11 | 1.28E-05 |
| Rnf213 | ring finger protein 213 | 2.08 | 1.59E-04 |
| H2-D1 | histocompatibility 2, D region locus 1 | 2.04 | 2.78E-06 |
| Ear2 | eosinophil-associated, ribonuclease A family, member 2 | 2.04 | 9.57E-04 |
| Sst | somatostatin | −2.01 | 1.25E-04 |
| Smim24 | small integral membrane protein 24 | −2.11 | 3.12E-05 |
| Muc5ac | mucin 5, subtypes A and C, tracheobronchial/gastric | −2.23 | 1.14E-03 |
| Lpl | lipoprotein lipase | −2.32 | 3.50E-04 |
| Sgk1 | serum/glucocorticoid regulated kinase 1 | −2.33 | 8.22E-05 |
| Ckb | creatine kinase, brain | −2.35 | 1.02E-04 |
| Gif | gastric intrinsic factor | −2.36 | 3.50E-04 |
| Cox7a1 | cytochrome c oxidase subunit VIIa 1 | −2.49 | 1.06E-04 |
| Ttr | transthyretin | −2.57 | 9.85E-06 |
| Dpcr1 | diffuse panbronchiolitis critical region 1 (human) | −2.57 | 1.05E-03 |
| Fabp3 | fatty acid binding protein 3, muscle and heart | −2.61 | 6.23E-05 |
| Atp4a | ATPase, H+/K+ exchanging, gastric, alpha polypeptide | −2.95 | 6.99E-04 |
| Apoa1 | apolipoprotein A-I | −3.13 | 1.23E-03 |
| Hamp2 | hepcidin antimicrobial peptide 2 | −3.45 | 1.25E-04 |
| Pdia2 | protein disulfide isomerase associated 2 | −3.57 | 7.21E-06 |
| Amy2a5 | amylase 2a5 | −4.09 | 1.74E-04 |
| Chia1 | chitinase, acidic 1 | −5.25 | 6.66E-04 |
Genes with no known annotated name were excluded from the analysis. Genes were considered to be statistically significant when a threshold adjusted p value < 0.05 and Log FC > 2 were reached
Fig. 4Network characterization of selected genes at 25 weeks. STRING gene networks of interactions of DEGs with a STRING interaction confidence of 0.7 or greater (high confidence) for H. felis-infected Myd88 mice at 25 weeks for both upregulated (a) and downregulated (b) genes. Known interactions are illustrated with light blue string attachments (from curated databases) and light pink/purple strings (experimentally determined). Co-expression are illustrated with black string attachments
Fig. 5Network characterization of selected genes at 47 weeks. STRING gene networks of interactions of DEGs with a STRING interaction confidence of 0.7 or greater (high confidence) for MyD88 - H. felis infected at 47 weeks both upregulated (a) and downregulated (b) genes. Known interactions are illustrated with light blue string attachments (from curated databases) and light pink/purple strings (experimentally determined). Co-expression are illustrated with black string attachments
Fig. 6Profiles of GO enrichment analysis. Enriched Go terms are shown for H. felis-infected Myd88 mice at both 25 (a, b) and 47 weeks (c, d). Biological processes are depicted in figures A and C while molecular functions are depicted in B and D. For the biological processes, the top 20 processes are shown. All scores depicted are relative scores for number of genes in each function/ process relative to the number of total genes entered into the STRING database
Fig. 7Venn Diagram showing distribution of different significantly enriched KEGG pathways. Pathways with p-value > E-04 are included. Antigen processing and presentation is the most enriched pathway overlapping the majority of genes with all other pathways. Notably, all processes are associated with inflammatory responses of the immune system